Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy

International Journal of Urology

Volumn 14, Issue 6, 2007, Pages 500-504

  Yokomizo, Akira ^a   Yamamoto, Ken ^a   Kinukawa, Naoko ^b   Tsunoda, Toshiyuki ^a   Koga, Hirofumi ^a   Naito, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

GSTP1; M VAC; Neutrocytopenia; Polymorphism; Urothelial cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; GLUTATHIONE TRANSFERASE P1; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; VINBLASTINE;

AGED; ALLELE; ANEMIA; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DNA POLYMORPHISM; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RISK; THROMBOCYTOPENIA; UROGENITAL TRACT CANCER; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOXORUBICIN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; LEUKOPENIA; MALE; METABOLIC DETOXICATION, DRUG; METHOTREXATE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; UROLOGIC NEOPLASMS; UROTHELIUM; VINBLASTINE;

EID: 34250878325     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01769.x     Document Type: Article

References (25)

1. Yokomizo A, Kohno K, Wada M et al. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis. J. Biol. Chem. 1995 270 : 19451 7.
2. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S- transferase family of enzymes. Mutat. Res. 2001 482 : 21 6.
3. Debes JD, Yokomizo A, McDonnell SK et al. Glutathione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet. Cytogenet. 2004 155 : 82 6.
4. Naito S, Koga H, Yokomizo A et al. Molecular analysis of mechanisms regulating drug sensitivity and the development of new chemotherapy strategies for genitourinary carcinomas. World J. Surg. 2000 24 : 1183 6.
5. Naito S, Yokomizo A, Koga H. Mechanisms of drug resistance in chemotherapy for urogenital carcinoma. Int. J. Urol. 1999 6 : 427 39.
6. Hemstreet GP III, Yin S, Ma Z et al. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J. Natl Cancer Inst. 2001 93 : 427 36.
7. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J. Clin. 1999 49 : 33 64.
8. Hu X, O'Donnell R, Srivastava SK et al. Active site architecture of polymorphic forms of human glutathione S-transferase P1-1 accounts for their enantioselectivity and disparate activity in the glutathione conjugation of 7beta,8alpha-dihydroxy-9alpha,10alpha-oxy-7,8,9,10-tetrahydrobenzo (a) pyrene. Biochem. Biophys. Res. Commun. 1997 : 235 : 424 8.
9. Johansson AS, Stenberg G, Widersten M, Mannervik B. Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J. Mol. Biol. 1998 278 : 687 98.
10. Mitrunen K, Jourenkova N, Kataja V et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol. Biomarkers Prev. 2001 10 : 229 36.
11. Park JY, Schantz SP, Stern JC, Kaur T, Lazarus P. Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 1999 9 : 497 504.
12. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997 18 : 641 4.
13. Kote-Jarai Z, Easton D, Edwards SM et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 2001 11 : 325 30.
14. Shepard TF, Platz EA, Kantoff PW et al. No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study. Cancer Epidemiol. Biomarkers Prev. 2000 9 : 1267 8.
15. Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur. Urol. 2005 48 : 339 44.
16. Ma Q, Lin G, Qin Y et al. GSTP1 A1578G (Ile105Val) polymorphism in benzidine-exposed workers: An association with cytological grading of exfoliated urothelial cells. Pharmacogenetics 2003 13 : 409 15.
17. Toruner GA, Akyerli C, Ucar A et al. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch. Toxicol. 2001 75 : 459 64.
18. Katoh T, Kaneko S, Takasawa S et al. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 1999 9 : 165 9.
19. Garcia-Closas M, Malats N, Silverman D et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005 366 : 649 59.
20. Miyazaki M, Kohno K, Saburi Y et al. Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene. Biochem. Biophys. Res. Commun. 1990 166 : 1358 64.
21. Sternberg CN, Yagoda A, Scher HI et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J. Urol. 1985 133 : 403 7.
22. Sternberg CN, Yagoda A, Scher HI et al. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J. Urol. 1988 139 : 461 9.
23. Sternberg CN, Yagoda A, Scher HI et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989 64 : 2448 58.
24. Weir BS. The second National Research Council report on forensic DNA evidence. Am. J. Hum. Genet. 1996 59 : 497 500.
25. Yang P, Yokomizo A, Tazelaar HD et al. Genetic determinants of lung cancer short-term survival: The role of glutathione-related genes. Lung Cancer 2002 35 : 221 9.